Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

By The American, Thyroid Association, Guidelines Taskforce, David S. Cooper, Chair, Gerard M. Doherty, B. R. Haugen, R. Kloos, Stephanie L. Lee, Susan J. Mandel and 6 more. Thyroid, 2006

2,148 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/584af5ccddd1cbed487127374414f94aabf6566b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Y. Nikiforov
2. D. Cooper
3. M. Nikiforova
4. B. Biondi

In Surgery

1. Y. Nikiforov
2. M. Nikiforova

Citations in the corpus

• Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy (2006, neutral): “*Presented in part at the 74th Annual Meeting (2001) and the 2nd Annual Spring Meeting (2005) of the American Thyroid Association.”
• Guidelines for radioiodine therapy of differentiated thyroid cancer (2008, background): “A TSH level of ≥30 mU/L is believed to increase NIS expression and thereby to optimise radioiodine uptake [13].”
• Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. (2006, background): “worrisome sonographic characteristics (10, 11).”
• Long‐term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation (2007, neutral): “9 54 (14) 4 43 (12) Unknown (not resected) 7 AJCC stage* I 253 (72) II 76 (21) III 21 (6) IV 4 (1) MACIS scorey \6 282 (88) 6–6.”
• Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association (2009, positive): “TheTask Force categorized our recommendations using criteria adapted from the United States Preventive Services Task Force, Agency for Healthcare Research and Quality (Table 3) as was used in the ATA publication Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cance”
• Extent of Surgery Affects Survival for Papillary Thyroid Cancer (2007, background): “5 cm in diameter or larger; however, these recommendations have not been based on a demonstrated survival difference.(5,9) The objective of this study was to examine whether the extent of surgery affects outcomes for PTC and to determine whether a size threshold could be identified above which total”
• Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. (2009, background): “terval before definitive diagnosis (5, 13).”